BIOMAT Database Logo BIOMAT Database Logo

Crossover pharmacokinetic analysis comparing intravenous and intraperitoneal administration of tobramycin. 1986

J J Walshe, and G D Morse, and D M Janicke, and M A Apicella

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014031 Tobramycin An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. Nebramycin Factor 6,Brulamycin,Nebcin,Nebicin,Obracin,Tobracin,Tobramycin Sulfate,Sulfate, Tobramycin

Related Publications

J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
[Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration].
September 1991, Zhonghua zhong liu za zhi [Chinese journal of oncology],
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
[Pharmacokinetic analysis of intraperitoneal cisplatinum administration].
March 1988, Nihon Gan Chiryo Gakkai shi,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
[Usefulness of intraperitoneal carboplatin administration-- pharmacokinetic analysis].
September 1992, Nihon Sanka Fujinka Gakkai zasshi,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
Timing of inhaled tobramycin affects assessment of intravenous tobramycin pharmacokinetic monitoring.
July 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.
May 2016, Antimicrobial agents and chemotherapy,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat.
March 2012, The Journal of pharmacy and pharmacology,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
[Tobramycin concentration in human aqueous humor after intravenous administration].
November 1987, Nippon Ganka Gakkai zasshi,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs.
September 2020, Journal of veterinary pharmacology and therapeutics,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
July 1997, Die Pharmazie,
J J Walshe, and G D Morse, and D M Janicke, and M A Apicella
Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis.
February 2014, Journal of pharmacokinetics and pharmacodynamics,
Copied contents to your clipboard!